Alhamadani, I.; Alzyadi, M.; Majeed, M. Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 Prognostic Value. Arch Breast Cancer 2026, 13, 154-165.